People’s Pharmacy: What might work better for fatigue than Ozempic
Both semaglutide and tirzepatide should help people with Type 2 diabetes lower their HbA1c, a measure of blood glucose over ...
Lexaria Bioscience announces PK results on DehydraTech-Tirzepatide oral capsules
Lexaria Bioscience (LEXX) announced pharmacokinetic results from Human Study #3 or GLP-1-H24-3, comparing an oral version of ...
BioSpace13d
GLP-1 Side Effects Only One Factor Driving Patient Discontinuation Rates
While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that ...
Lexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly’s Injectable Zepbound(R)
Detailed price information for Lexaria Bioscience Corp (LEXX-Q) from The Globe and Mail including charting and trades.
MedPage Today7d
Hair Loss: Another Wegovy Side Effect?
However, no tirzepatide-treated patients discontinued ... and gastroparesis -- all known side effects of the GLP-1 agonist class -- could also increase risk of hair loss, they added.
Zepbound copycats remain online despite FDA ban
Copycat versions of Eli Lilly’s diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. They’re still available on some websites.
Diabetes.co.uk11d
Retatrutide: How it Works, Evidence, Side Effects
Retatrutide mimics the effects of naturally occurring gut hormones to improve metabolic health. Stimulating insulin release ...
Mounjaro can boost weight loss in people without diabetes
People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...